{
  "ticker": "JNJ",
  "target_date": "2025-05-23",
  "actual_date": "2025-05-23",
  "collected_at": "2025-12-08T11:48:11.494788",
  "price": {
    "open": 149.64,
    "high": 150.11,
    "low": 148.87,
    "close": 149.58531188964844,
    "volume": 6727300,
    "change_1d_pct": 0.22,
    "change_7d_pct": 4.5,
    "change_30d_pct": 2.86
  },
  "technicals": {
    "rsi_14": 45.52,
    "sma_20": 150.11,
    "sma_50": 152.59,
    "macd": -1.05,
    "macd_signal": -1.278,
    "macd_histogram": 0.228,
    "bb_upper": 155.55,
    "bb_lower": 144.67,
    "price_vs_sma20_pct": -0.35,
    "price_vs_sma50_pct": -1.97,
    "volume_ratio": 0.86
  },
  "fundamentals": {
    "market_cap": 489267593216,
    "pe_ratio": 19.601835,
    "forward_pe": 19.158018,
    "price_to_book": 6.163687,
    "price_to_sales": 5.309527,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.28,
    "pct_from_52w_low": 44.35
  },
  "macro": {
    "spy": {
      "price": 575.81,
      "change_1d_pct": -0.68,
      "change_7d_pct": -1.92
    },
    "vix": {
      "level": 22.29,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.51
    },
    "dollar_index": {
      "level": 99.11
    },
    "gold": {
      "price": 3363.6
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Why Investors Should Watch Teva Despite Regional Risks",
      "source": "SeekingAlpha",
      "datetime": 1748004723,
      "summary": "Teva Pharmaceuticals continues to beat consensus estimates, has once again raised its 2025 financial guidance and secured credit upgrades. Read more on why TEVA stock is a Buy.",
      "url": "https://finnhub.io/api/news?id=cf24b2a0bb360e2a3e02f53e94632fe654e0bd890ffdc8997680f5ed687da4e5"
    },
    {
      "headline": "Johnson & Johnson to Participate in the Bernstein's 41st Annual Strategic Decisions Conference",
      "source": "Finnhub",
      "datetime": 1747998614,
      "summary": "New Brunswick, N.J.- Johnson & Johnson will present at the Bernstein's 41st Annual Strategic Decisions Conference on Wednesday, May 28th, 2025. Management will participate in a Fireside Chat at 9:00...",
      "url": "https://finnhub.io/api/news?id=595a21ada1be673dbd2b912f97bac887e4f26c33303a84bdebb2ad55da2b244d"
    },
    {
      "headline": "J&J: to present 70 abstracts at the ASCO conference",
      "source": "Finnhub",
      "datetime": 1747995773,
      "summary": "Johnson & Johnson announces that more than 70 abstracts, including 13 oral presentations, from its oncology portfolio will be presented at the ASCO 2025 and EHA 2025 conferences. The data relate to...",
      "url": "https://finnhub.io/api/news?id=19e40a93ac92ac735f3f467f2287baa046a0f6c1f622badaa4b2be437186370e"
    },
    {
      "headline": "Alerts on J&J from law firm's press release withdrawn",
      "source": "Finnhub",
      "datetime": 1747987627,
      "summary": "Alerts on FDA panel reiteratingcancer risks of talc were inadvertently published off a pressrelease from a law firm and has been withdrawn. There will be no substitute. ...",
      "url": "https://finnhub.io/api/news?id=99a2dbcd7a64a378fa9203b57d3c4b1f86f75d5cf27718b4ed1fec48fb8947d3"
    },
    {
      "headline": "FDA Panel Reiterates the Cancer Risks of Talc",
      "source": "Finnhub",
      "datetime": 1747987324,
      "summary": "Links of ovarian cancer to baby powder use raise concerns about use in cosmetics, food, drugs...",
      "url": "https://finnhub.io/api/news?id=a204176d5400598dd9c8ec910159dafdec2a6a4973538b3307f2fa2e39ca91fa"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "13F-HR",
      "date": "2025-05-07",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000238/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "4",
      "date": "2025-05-05",
      "description": "xslF345X05/wk-form4_1746479407.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000143/xslF345X05/wk-form4_1746479407.xml"
    },
    {
      "form": "8-K",
      "date": "2025-04-30",
      "description": "jnj-20250424.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000141/jnj-20250424.htm"
    },
    {
      "form": "4",
      "date": "2025-04-28",
      "description": "xslF345X05/wk-form4_1745877468.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000138/xslF345X05/wk-form4_1745877468.xml"
    },
    {
      "form": "4",
      "date": "2025-04-28",
      "description": "xslF345X05/wk-form4_1745877247.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000135/xslF345X05/wk-form4_1745877247.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}